Peptide-based Delivery of Therapeutic Nucleic Acids Targeting Neurodegenerative Diseases
Implementing Organization
Centre for Cellular and Molecular Biology (CCMB)
About
The technology pertains to the potential and utility of TARBP-BTP, a new fusion protein that fosters the efficient delivery of siRNA to the brain and hence mediate the knockdown of target genes responsible for early onset of neurodegenerative disorders and would also serve unmet needs for incurable neurological conditions. e.g. Huntington's Disease, Alzheimer's Disease (AD).
Patents
US10208098
Outcome / Output
An excellent method for delivering siRNA across the blood-brain barrier for the intervention of neurodegenerative diseases.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Centre for Cellular and Molecular Biology (CCMB)
Acces sibility Controls